---
id: aao-glaucoma-2024
title: "AAO 2024 Preferred Practice Pattern: Primary Open-Angle Glaucoma"
short_title: "AAO POAG 2024"

organization: American Academy of Ophthalmology
collaborators: null
country: US
url: https://www.aao.org/preferred-practice-pattern
doi: null
pmid: null
open_access: true

specialty: ophthalmology
guideline_type: clinical-practice
evidence_system: AAO
conditions:
  - glaucoma
  - primary open-angle glaucoma
  - POAG
tags:
  - intraocular pressure
  - prostaglandin analogs
  - visual field
  - optic nerve
  - MIGS

publication_date: 2024-09-01
previous_version_date: 2021-01-01
status: current
supersedes: null
superseded_by: null

pdf_path: null
has_pdf: false
last_reviewed: 2025-12-26
---

## Scope
2024 AAO Preferred Practice Pattern update on the diagnosis and management of primary open-angle glaucoma (POAG).

## Key Recommendations

### Diagnosis
- **Optic Nerve Assessment**: Cupping, notching, RNFL defects on OCT.
- **Intraocular Pressure (IOP)**: May be elevated (>21 mmHg) but can be normal (normal-tension glaucoma).
- **Visual Field Testing**: Perimetry to detect characteristic field loss.
- **OCT RNFL/GCC**: Objective measurement of nerve fiber layer and ganglion cell complex.
- **Gonioscopy**: To confirm open angle and rule out secondary causes.

### Risk Factors
- Elevated IOP, family history, advanced age, African ancestry, thin central corneal thickness, myopia.

### Treatment Goals
- Lower IOP to a target that prevents or slows progression.
- Target IOP is individualized (typically 20-30% reduction or lower based on severity).

### Medical Therapy

#### First-Line
- **Prostaglandin Analogs (Latanoprost, Bimatoprost, Travoprost, Latanoprostene Bunod)**: Most effective at lowering IOP; once-daily dosing.

#### Second-Line / Adjuncts
- **Beta-Blockers (Timolol)**.
- **Alpha-Agonists (Brimonidine)**.
- **Carbonic Anhydrase Inhibitors (Dorzolamide, Brinzolamide; Oral: Acetazolamide)**.
- **Rho Kinase Inhibitors (Netarsudil)**.
- **Fixed-Dose Combinations**: Improve adherence.

### Laser Therapy
- **Selective Laser Trabeculoplasty (SLT)**: May be used as initial or adjunctive therapy; repeatable.

### Surgical Therapy
- **Trabeculectomy**: Standard filtering surgery for refractory glaucoma.
- **Glaucoma Drainage Devices (Tube Shunts)**: Ahmed, Baerveldt.
- **Minimally Invasive Glaucoma Surgery (MIGS)**: iStent, Hydrus, goniotomy, XEN gel stent. Less invasive; suitable for mild-moderate glaucoma or combined with cataract surgery.

### Follow-Up
- Regular IOP checks, visual field, OCT to monitor for progression.
